Trial intelligence / Profile preview

Fluoxetine and 5-HT4 agonists effects on cerebral metabolism in multiple sclerosis

2010-023996-25Phase 4Completed

Start: Nov 2010
Modality: Small Molecules
Countries: 1

Overview

Phase 4 trial of fluoxetine, cisapride and prucalopride in multiple sclerosis (MS). Primary endpoints: MRS: N-acetylaspartate (NAA) levels and MRS: glutamate levels. Started Nov 2010; status: completed.

Drugs

fluoxetinecisaprideprucalopride

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on 2010-023996-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023996-25.